J. Safra Sarasin Holding Ag Intra Cellular Therapies, Inc. Transaction History
J. Safra Sarasin Holding Ag
- $5.47 Trillion
- Q2 2024
A detailed history of J. Safra Sarasin Holding Ag transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, J. Safra Sarasin Holding Ag holds 31,369 shares of ITCI stock, worth $2.34 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
31,369Holding current value
$2.34 Million% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding ITCI
# of Institutions
400Shares Held
87.2MCall Options Held
309KPut Options Held
302K-
Vanguard Group Inc Valley Forge, PA9.61MShares$718 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$472 Million0.01% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.72MShares$278 Million1.37% of portfolio
-
Jpmorgan Chase & CO New York, NY3.44MShares$257 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY3MShares$224 Million2.8% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $7.05B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...